PMV Pharmaceuticals, Inc
Filings
Newest firstThe annual , the quarterly and the filed between them when something material happens.
- Oct 58-KOfficer or director change and Regulation FD disclosure5.027.019.01
- Sep 1513GPassive stake of 5% or more (13G), filed by Samsara BioCapital
- Sep 18-KMaterial agreement and other events1.018.019.01
- Sep 1424B5Prospectus for an offering
- Aug 31424B3Prospectus for an offering
- Aug 31424B5Prospectus for an offering
- Aug 318-KOther events8.019.01
- Aug 1410-QQuarterly report
- Aug 148-KResults of operations2.029.01
- Jun 58-KShareholder vote5.07
- May 1210-QQuarterly report
- May 128-KResults of operations2.029.01
- Mar 68-KResults of operations2.029.01
- Mar 610-KAnnual report
- Nov 12, 202510-QQuarterly report
- Nov 12, 20258-KResults of operations2.029.01
- Sep 10, 20258-KRegulation FD disclosure and other events7.018.019.01
- Aug 7, 202510-QQuarterly report
- Aug 7, 20258-KResults of operations2.029.01
- Jun 9, 20258-KShareholder vote5.07
- May 9, 202510-QQuarterly report
- May 9, 20258-KResults of operations2.029.01
- Mar 3, 202510-KAnnual report
- Mar 3, 20258-KResults of operations2.029.01
- Nov 27, 2024424B3Prospectus for an offering
- Nov 20, 2024S-3Shelf registration
- Nov 7, 202410-QQuarterly report
- Nov 7, 20248-KResults of operations2.029.01